Skip to content

Neuropsychomotor Functions in Children With Autism Spectrum Disorder

Neuropsychomotor Functions in Children With Autism Spectrum Disorder

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01987037
Enrollment
40
Registered
2013-11-19
Start date
2013-10-31
Completion date
2016-02-29
Last updated
2015-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Keywords

autism spectrum disorder, neuropsychomotor assessment, NP-MOT, motor skills, gross motor

Brief summary

The aim of the study is to describe the feasibility of the passation of the assessment battery of psychomotor functions tests (NP-MOT) in children aged 4 to 11 years with a diagnosis of autism spectrum disorder: number and type of evaluable events, number and type of tests with a deficit compared to the standard results.

Detailed description

After informed consent obtention, the children will be submitted to the different tests of the battery to evaluate the psychomotor functions. The results will be compared with other data collected from the routine practise : socio-demographic data, medical and developmental antecedents,psychological tests (KABC II, Rey test, London Tower test, ...), psychomotor evaluation (MABC, evaluation of manual praxis, visual abilities, Frostig test), understanding data (N-EEL test), neuropediatric examination, clinical assessment (ADI-R, CARS). The use of this battery allows this fine discriminative assessment of the psychomotor functions involved in the movement. Exploring each function will allow to take into account qualitative and quantitative aspects of the movement in every aspects, and this is not applied in the routine care until now. Calibration for each event can explore each function independently of each other, and will provide information to determine any specific developmental characteristics improve care.

Interventions

BEHAVIORALneuropsychomotor assessment

Children with autism spectrum disorders pass a specific battery test (NP-MOT) for a neuropsychomotor assessment. This neuropsychomotor assessment is administered in a half-day maximum. This battery aims to investigate passive muscle tone (shoulders, limbs, and trunk), standing and synkinesia, static and dynamic balance, tonic laterality (extensibility and dangling of hands and feet to identify the tonic dominant side), laterality of use, fine-digit movements, digital tactile gnosis, and body spatial integration (knowing left from right: for oneself and that of others, and with regard to objects).

Sponsors

Centre Hospitalier Esquirol
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
4 Years to 11 Years
Healthy volunteers
No

Inclusion criteria

* informed consent from the parents or the legal representative * age 4 to 11 * autism spectrum disorder diagnosis according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition- text revised

Exclusion criteria

* bad understanding of the french language * motor disability from lesion or accidental origin, proved genetic or neurologic disease * deafness, blindness * parents with administrative or judiciary protection, and without health insurance

Design outcomes

Primary

MeasureTime frameDescription
results to the NP-MOT tests batteryone daythe NP-MOT battery tests include several tests to evaluate 9 motor functions (muscle tone, gross motor, laterality, fine-digit movement, digital tactile gnosis, hand-eye skill, body spatial orientation, pace, auditory attention) with 48 subtests. We describe: number and type of evaluable tests, number and type of tests with results with 1 Standard Deviation different from the standard results. number and type of tests with results with 2 Standard Deviation different from the standard results.

Countries

France

Contacts

Primary ContactAude Paquet
audepaquet@gmail.com0033555431010
Backup ContactMurielle Girard, PhD
murielle.girard@ch-esquirol-limoges.fr0033555431028

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026